Sangamo Therapeutics
Insider trading & Transactions

Last updated: 16 Mar 2015

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Option	16 Mar 2015	LANPHIER EDWARD O II director director	Common Stock	25,000	N/A	N/A
Option	16 Mar 2015	LANPHIER EDWARD O II director director	Employee Stock Option (Right to Buy)	25,000	N/A	N/A
Sale	16 Mar 2015	LANPHIER EDWARD O II director director	Common Stock	25,000	N/A	N/A
Option	10 Mar 2015	WOLFF HENRY WARD officer: Exec VP & CFO officer: Exec VP & CFO	Common Stock	10,000	N/A	N/A
Option	10 Mar 2015	WOLFF HENRY WARD officer: Exec VP & CFO officer: Exec VP & CFO	Employee Stock Option (Right to Buy)	10,000	N/A	N/A
Sale	10 Mar 2015	WOLFF HENRY WARD officer: Exec VP & CFO officer: Exec VP & CFO	Common Stock	12,000	N/A	N/A
Sale	5 Mar 2015	MENTO STEVEN J director director	Common Stock	6,501	N/A	N/A
Option	5 Mar 2015	MENTO STEVEN J director director	Common Stock	10,000	N/A	N/A
Option	5 Mar 2015	MENTO STEVEN J director director	Employee Stock Option (Right to Buy)	10,000	N/A	N/A
Option	5 Mar 2015	ANDO DALE G officer: VP, Therapeutic Dev. & CMO officer: VP, Therapeutic Dev. &..	Common Stock	15,000	N/A	N/A
Sale	5 Mar 2015	ANDO DALE G officer: VP, Therapeutic Dev. & CMO officer: VP, Therapeutic Dev. &..	Common Stock	15,000	N/A	N/A
Option	5 Mar 2015	ANDO DALE G officer: VP, Therapeutic Dev. & CMO officer: VP, Therapeutic Dev. &..	Employee Stock Option (Right to Buy)	15,000	N/A	N/A
Option	4 Mar 2015	WOLFF HENRY WARD officer: Exec VP & CFO officer: Exec VP & CFO	Employee Stock Option (Right to Buy)	10,000	N/A	N/A
Option	4 Mar 2015	WOLFF HENRY WARD officer: Exec VP & CFO officer: Exec VP & CFO	Common Stock	10,000	N/A	N/A
Sale	4 Mar 2015	WOLFF HENRY WARD officer: Exec VP & CFO officer: Exec VP & CFO	Common Stock	10,000	N/A	N/A
Sale	3 Mar 2015	RINGO WILLIAM R director director	Common Stock	2,200	N/A	N/A
Option	3 Mar 2015	RINGO WILLIAM R director director	Stock Option (Right to Buy)	2,200	N/A	N/A
Option	3 Mar 2015	RINGO WILLIAM R director director	Common Stock	2,200	N/A	N/A
Option	2 Mar 2015	GREGORY PHILIP D officer: SVP of Research & CSO officer: SVP of Research & CSO	Employee Stock Option (Right to Buy)	15,000	N/A	N/A
Sale	2 Mar 2015	GREGORY PHILIP D officer: SVP of Research & CSO officer: SVP of Research & CSO	Common Stock	15,000	N/A	N/A
Option	2 Mar 2015	GREGORY PHILIP D officer: SVP of Research & CSO officer: SVP of Research & CSO	Common Stock	15,000	N/A	N/A
Option	17 Feb 2015	LANPHIER EDWARD O II director director	Common Stock	25,000	N/A	N/A
Option	17 Feb 2015	LANPHIER EDWARD O II director director	Employee Stock Option (Right to Buy)	25,000	N/A	N/A
Sale	17 Feb 2015	LANPHIER EDWARD O II director director	Common Stock	25,000	N/A	N/A
Option	12 Feb 2015	RAMASASTRY SAIRA director director	Common Stock	10,000	N/A	N/A
Sale	12 Feb 2015	RAMASASTRY SAIRA director director	Common Stock	10,000	N/A	N/A
Option	12 Feb 2015	RAMASASTRY SAIRA director director	Employee Stock Option (Right to Buy)	10,000	N/A	N/A
Option	10 Feb 2015	WOLFF HENRY WARD officer: Exec VP & CFO officer: Exec VP & CFO	Common Stock	10,000	N/A	N/A
Option	10 Feb 2015	WOLFF HENRY WARD officer: Exec VP & CFO officer: Exec VP & CFO	Employee Stock Option (Right to Buy)	10,000	N/A	N/A
Sale	10 Feb 2015	WOLFF HENRY WARD officer: Exec VP & CFO officer: Exec VP & CFO	Common Stock	12,000	N/A	N/A
Sale	5 Feb 2015	ANDO DALE G officer: VP, Therapeutic Dev. & CMO officer: VP, Therapeutic Dev. &..	Common Stock	15,000	N/A	N/A
Option	5 Feb 2015	ANDO DALE G officer: VP, Therapeutic Dev. & CMO officer: VP, Therapeutic Dev. &..	Common Stock	15,000	N/A	N/A
Option	5 Feb 2015	ANDO DALE G officer: VP, Therapeutic Dev. & CMO officer: VP, Therapeutic Dev. &..	Employee Stock Option (Right to Buy)	15,000	N/A	N/A
Sale	3 Feb 2015	RINGO WILLIAM R director director	Common Stock	2,200	N/A	N/A
Option	3 Feb 2015	RINGO WILLIAM R director director	Stock Option (Right to Buy)	2,200	N/A	N/A
Option	3 Feb 2015	RINGO WILLIAM R director director	Common Stock	2,200	N/A	N/A
Option	2 Feb 2015	GREGORY PHILIP D officer: SVP of Research & CSO officer: SVP of Research & CSO	Common Stock	15,000	N/A	N/A
Option	2 Feb 2015	GREGORY PHILIP D officer: SVP of Research & CSO officer: SVP of Research & CSO	Employee Stock Option (Right to Buy)	15,000	N/A	N/A
Sale	2 Feb 2015	GREGORY PHILIP D officer: SVP of Research & CSO officer: SVP of Research & CSO	Common Stock	15,000	N/A	N/A
Sale	16 Jan 2015	LANPHIER EDWARD O II director director	Common Stock	10,000	N/A	N/A
Option	16 Jan 2015	LANPHIER EDWARD O II director director	Common Stock	10,000	N/A	N/A
Option	16 Jan 2015	LANPHIER EDWARD O II director director	Employee Stock Option (Right to Buy)	10,000	N/A	N/A
Sale	15 Jan 2015	LANPHIER EDWARD O II director director	Common Stock	15,000	N/A	N/A
Option	15 Jan 2015	LANPHIER EDWARD O II director director	Common Stock	15,000	N/A	N/A
Option	15 Jan 2015	LANPHIER EDWARD O II director director	Employee Stock Option (Right to Buy)	15,000	N/A	N/A
Option	12 Jan 2015	WOLFF HENRY WARD officer: Exec VP & CFO officer: Exec VP & CFO	Common Stock	10,000	N/A	N/A
Option	12 Jan 2015	WOLFF HENRY WARD officer: Exec VP & CFO officer: Exec VP & CFO	Employee Stock Option (Right to Buy)	10,000	N/A	N/A
Sale	12 Jan 2015	WOLFF HENRY WARD officer: Exec VP & CFO officer: Exec VP & CFO	Common Stock	12,000	N/A	N/A
Option	5 Jan 2015	LARSON JOHN WILLIAM director director	Common Stock	15,000	N/A	N/A
Option	5 Jan 2015	LARSON JOHN WILLIAM director director	Stock Option (Right to Buy)	5,000	N/A	N/A

Showing 250 to 300 of 1018 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Sangamo Therapeutics Insider trading & Transactions

Insider trading

Who is insider?

Similar companies insider trading:

Sangamo Therapeutics
Insider trading & Transactions